Aim & Scope

European Journal of Molecular & Clinical Medicine (EJMCM) is the official publication of the European Society for Translational Medicine. EJMCM publishes high quality manuscripts covering all aspects of molecular and clinical medicine. Submitted manuscripts are peer reviewed and selection is based on scientific excellence, distinctive contribution to knowledge and importance to the field. To provide a single platform for immediate dissemination of latest discoveries & developments from benchside and bedside, EUSTM has merged both of the Society’s journals; ‘New Horizons in Translational Medicine’ and ‘New Horizons in Clinical Case Reports’ into one publication: European Journal of Molecular & Clinical Medicine (EJMCM) Molecular Medicine Section: Special consideration will be given to novel findings generated in cellular and molecular biology, genetics, stem cell biology, microbiology, immunology and the omics disciplines. In addition, quality manuscripts describing novel developments in the field of biomarkers, disease modelling, large data set mining will be considered for publication. Clinical Medicine Section: Special consideration will be given to high quality clinical studies and case reports from all clinical specialties. Manuscripts should provide new insight and contribute to advance medical knowledge. ^[1]

_{Go to Website}

Continuations

(  2017  -  2017  )	New Horizons in Clinical Case Reports		(  2017  -  9999  )	European Journal of Molecular and Clinical Medicine (EJMCM)
(  2013  -  2017  )	New Horizons in Translational Medicine (NHTM)		(  2017  -  9999  )	European Journal of Molecular and Clinical Medicine (EJMCM)